Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venu Menon

Showing results (311-320 of 348) with videos related to

Pageof 35
Sort By:
Circulation|July 17, 2013
Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart AssociationMary Ann Peberdy, Michael W Donnino, Clifton W Callaway, et al.
European Urology|March 18, 2014
Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trialCheryl T Lee, Sam S Chang, Ashish M Kamat, et al.
European Heart Journal. Acute Cardiovascular Care|January 5, 2022
End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) RegistryAntonio Fagundes, David D Berg, Erin A Bohula, et al.
European Heart Journal|April 3, 2009
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromesDeepak L Bhatt, Eric D Peterson, Robert A Harrington, et al.
European Heart Journal|October 12, 2017
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) TrialFrank Ruschitzka, Jeffrey S Borer, Henry Krum, et al.
The New England Journal of Medicine|December 14, 2016
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for ArthritisSteven E Nissen, Neville D Yeomans, Daniel H Solomon, et al.
Circulation|June 15, 2011
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research ConsortiumRoxana Mehran, Sunil V Rao, Deepak L Bhatt, et al.
JAMA Cardiology|May 16, 2021
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH TrialSteven E Nissen, A Michael Lincoff, Kathy Wolski, et al.
European Heart Journal Open|August 4, 2022
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammationPaul C Cremer, Calvin C Sheng, Debasis Sahoo, et al.
Journal of the American College of Cardiology|September 17, 2013
Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet needSachin S Goel, Navkaranbir Bajaj, Bhuvnesh Aggarwal, et al.
Pageof 35

Showing results (311-320 of 348) with videos related to

Sort By:
Pageof 35
Circulation|July 17, 2013
Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart AssociationMary Ann Peberdy, Michael W Donnino, Clifton W Callaway, et al.
European Urology|March 18, 2014
Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trialCheryl T Lee, Sam S Chang, Ashish M Kamat, et al.
European Heart Journal. Acute Cardiovascular Care|January 5, 2022
End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) RegistryAntonio Fagundes, David D Berg, Erin A Bohula, et al.
European Heart Journal|April 3, 2009
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromesDeepak L Bhatt, Eric D Peterson, Robert A Harrington, et al.
European Heart Journal|October 12, 2017
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) TrialFrank Ruschitzka, Jeffrey S Borer, Henry Krum, et al.
The New England Journal of Medicine|December 14, 2016
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for ArthritisSteven E Nissen, Neville D Yeomans, Daniel H Solomon, et al.
Circulation|June 15, 2011
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research ConsortiumRoxana Mehran, Sunil V Rao, Deepak L Bhatt, et al.
JAMA Cardiology|May 16, 2021
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH TrialSteven E Nissen, A Michael Lincoff, Kathy Wolski, et al.
European Heart Journal Open|August 4, 2022
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammationPaul C Cremer, Calvin C Sheng, Debasis Sahoo, et al.
Journal of the American College of Cardiology|September 17, 2013
Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet needSachin S Goel, Navkaranbir Bajaj, Bhuvnesh Aggarwal, et al.
Pageof 35